At the conclusion of our educational meeting, the participant will be able to:

  • Acquaint with the new staging and pathology classification systems in lung cancer
  • Recognize the clinical significance of molecular genotyping of lung cancer patients
  • Understand the molecular pathways that hold promise for therapeutic intervention in lung cancer patients
  • Update of Immunotherapy strategies for lung cancer
  • Discuss the optimal methodology of evaluation of response in the era of translational research
  • Recognize the importance of a multidisciplinary approach to the care lung cancer patients




  • New IASLC lung cancer staging system
  • New WHO lung cancer pathology classification
  • Neuroendocrine lung cancer update
  • Thymic cancer update
  • Tumor heterogeneity
  • Prognostic and predictive tumor markers
  • Molecular signaling of LC
  • NSCLC driver oncogenes
  • Immunotherapy
  • Evaluation of response
  • Masterprotocols in lung cancer.
  • Agents related-toxicity management
  • Newer generation TKIs inhibitors




Learning Objectives & Topics

3rd Congress of the Mediterranean Multidisciplinary Oncology Forum

Best of WCLC

Congress Secretariat


E.T.S. Events & Travel Solutions S.A.
154 El. Venizelou Str
N. Smyrni, Athens, Greece, 171 22
Tel.: +30 210 98 80 032
Fax.: +30 210 98 81 303
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.events.gr

Scroll to top